Corporate

You heard it here first.

 
 
 

Our news

Bringing you the latest!

Corporate

The MedinCell General Meeting votes to include the “Raison d’être” of the Company in its articles of association

Corporate

10 September 2019

Third long-acting injectable antipsychotic using MedinCell’s technology enters preclinical development

Corporate

9 July 2019

MedinCell wins the #LetsgoFrance 2019 trophy in the category “France, a model of sustainable economy” (in French)

Corporate

5 April 2019

MedinCell demonstrates in vivo the efficacy of the first injectable combining surgical anesthesia and 3 days opioid free postoperative pain management

Corporate

11 March 2019

MedinCell receives 2nd part of the grant from the Bill & Melinda Gates Foundation

Corporate

24 January 2019

 
 

CONTACT

  • This field is for validation purposes and should be left unchanged.